In This Section

Program

SUNDAY, NOVEMBER 17

Monday, NOVEMBER 18

Tuesday, NOVEMBER 19

Wednesday, NOVEMBER 20

Sunday, November 17

REGISTRATION
4-8 P.M.

Welcome and Introduction
5:30-6:15 P.M.

  • Mikala Egeblad, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
  • Neta Erez, Tel Aviv University, Tel Aviv, Israel
  • Sergei Grivennikov, Cedars-Sinai Medical Center, Los Angeles, California
  • Ilaria Malanchi, The Francis Crick Institute, London, England

Opening Keynote Address
6:15-7P.M.
CME-Eligible

  • Introduction of keynote speaker
  • Title to be announced
    Ashani T. Weeraratna, John Hopkins University, Baltimore, Maryland
Monday, November 18

Continental Breakfast
7-8 a.m.

Plenary Session 1: Organ-Specific Microenvironments and Metastasis
8-10 a.m.
CME-Eligible

  • Understanding and overcoming the numbers game that underlies disseminated tumor cell immune evasion
    Cyrus M.  Ghajar, Fred Hutch Cancer Center, Seattle, Washington
  • Title to be announced
    Ilaria Malanchi, The Francis Crick Institute, London, United Kingdom
  • Dissecting plasticity during colorectal cancer metastasis
    Karuna Ganesh, Memorial Sloan-Kettering Cancer Center, New York, New York

Short-talks from highly-rated abstract

Break
10-10:30 a.m.

Plenary Session 2: Systemic Macroenvironment and Metastasis: Effects of Aging and Stress
10:30 a.m.-12:30 P.M.
CME-Eligible

  • Title to be announced
    Mikala Egeblad, Cold Spring Harbor Laboratory, Cold Spring Harbor, New York
  • Understanding the immune macroenvironment to improve outcomes for older breast cancer patients
    Sandra S. McAllister, Brigham and Women’s Hospital, Boston, MA
  • Respiratory virus infections promote metastatic outgrowth through alterations in immune landscapes
    James V. DeGregori, University of Colorado Anschutz Medical Campus, Aurora, Colorado

Short-talks from highly-rated abstract

Lunch on Own
12:30-2:30 P.M.

Plenary Session 3: The Metabolic Microenvironment, including Immune Metabolism
2:30-4:30 P.M.
CME-Eligible

  • Systemic and local metabolites controlling cancer immunity
    Greg M. Delgoffe, University of Pittsburgh, Pittsburgh, Pennsylvania
  • Modulating amino acid cross talk between cancer and the host to improve diagnosis and therapy
    Ayelet Erez, Weizman Institute of Science, Rehovot, Israel
  • Metabolic networks in the tumor microenvironment 
    Costas Lyssiotis, University of Michigan, Ann Arbor, Michigan

Short-talks from highly-rated abstract

Break
4:30 pm-5:00 P.M.

Plenary Session 4: Metabolic Macroenvironment: Obesity and Cancer Cachexia
5-7 P.M.
CME-Eligible

  • Intratumoral immune cells and their role in cancer cachexia
    Marcus DaSilva Gonsalves, Weill Cornell Medicine, New York, New York
  • Lydia Lynch, Brigham and Women’s Hospital, Boston, Massachusetts
  • Swarnali Acharya, Columbia University, New York, New York

Short-talks from highly-rated abstract

Lightning Talks
7:30-9 p.m.

POSTER SESSION A AND RECEPTION
7-8:30 P.M.

Tuesday, November 19

Continental Breakfast
7-8 a.m.

Plenary Session 5: Stromal Changes as Tissue Becomes Tumor: The Expanding Functions of TME Components
8-10:15 a.m.
CME-Eligible

  • Neta Erez, Tel Aviv University, Tel Aviv, Israel
  • Edna Cukierman, Fox Chase Cancer Center, Philadelphia, Pennsylvania
  • Kairbaan Hodivala-Dilke, Cancer Research UK, London, United Kingdom
  • Vascular control of metastasis
    Hellmut, Augustin, Heidelberg University & German Cancer Research Center (DKFZ) Heidelberg, Germany

Short-talk from highly-rated abstract

BREAK
10:15-10:45 a.m.

Plenary Session 6: Multicellular Interactions within Tumor Immune Microenvironments
10:45 A.m-12:45 p.m.
CME-Eligible

  • Lisa Coussens, Oregon Health and Science University, Portland, Oregon
  • Modulation of pancreatic tumor microenvironment and immune response
    Yulia Pylaeva-Gupta, University of North Carolina, Chapel Hill, Chapel Hill, North Carolina
  • Cedric Blanpain, Free University of Brussels, Brussels, Belgium 

Short-talks from highly-rated abstract

Lunch on own
12:45-2:30 p.m.

Plenary Session 7: Inflammation, the Immune Microenvironment, and the Systemic Interface
2:30-4:30 p.m.
CME-Eligible

  • Title to be announced
    Leah M. Cook, Nebraska Medical Center, Omaha, Nebraska
  • Microbes and cytokines regulating tumor microenvironment and metastasis 
    Sergei Grivennikov, Cedars-Sinai Medical Center, Los Angeles, California
  • Dissecting how breast tumours hijack myelopoiesis to promote metastasis
    Karin E. de Visser, Netherlands Cancer Institute, Amsterdam, Netherlands

Short-talks from highly-rated abstract

LIGHTNING TALKS
4:30-5 P.M.

POSTER SESSION B AND RECEPTION
4:30-6 P.M.

Wednesday, November 20

Continental Breakfast
7-8 a.m.

Plenary Session 8: Microbiome and Immune Therapy
8-10 a.m.
CME-Eligible

  • Systemic and local metabolites controlling cancer immunity
    Susan Bullman, Fred Hutch Cancer Center, Seattle, Washington
  • Florencia McAllister, University of Texas MD Anderson Cancer Center, Houston, Texas
  • Giorgio Trinchieri, National Institute of Health, Bethesda, Maryland

Short-talks from highly-rated abstract

BREAK
10-10:30 a.m.

Plenary Session 9: Therapy-induced Changes in Organ-specific Microenvironment and Therapeutic Strategies for Targeting the TME
10:30 a.m-12:30 p.m.
CME-Eligible

  • Title to be announced
    Adrienne Boire, Memorial Sloan Kettering Cancer Center, New York, New York
  • Age-related stromal changes drive tumorigenesis
    Sheila A. Stewart, Washington University School of Medicine, St. Louis, Missouri
  • Implicit order, disease, and cancer 
    Garry P. Nolan, Stanford University School of Medicine, Stanford, California

Short-talks from highly-rated abstract

CLOSING REMARKS
12:30 P.M.